Grant: Discovery Grants Program - Individual
University of British Columbia
$37,210.00
Axonal plasticity and the p75 neurotrophin receptor
EF 2007-08
Résumé
A balance between positive and negative influences govern the ability of nerve fibres (axons) to grow in the adult nervous system. Positive factors include a class of proteins known as neurotrophins, which if artificially provided in large amounts, are known to enhance axonal regeneration in the injured central nervous system CNS. Negative factors include proteins found in myelin, the insulation surrounding CNS axons. Blocking myelin's effects also improves axonal growth in the CNS. Both neurotrophins and myelin exert their effects on axons through complexes of receptors. Intriguingly, both complexes involve a receptor called p75, and genetically deleting p75 results in improved growth of axons in the CNS. Importantly, p75 deletion results in growth that is superior to that when all of the myelin-derived inhibitory proteins are blocked, and even when myelin is absent altogether. This suggests that p75 may also interfere with the growth-promoting ability of endogenously-expressed neurotrophins (those upregulated in response to injury). This proposal seeks to understand the mechanisms behind p75's role in preventing axon growth. It will use a combination of whole-animal (rats and mice) and tissue culture experiments to test the hypothesis that in the absence of p75 function, axon growth is enhanced due to increased efficacy of neurotrophins upregulated following CNS damage. We will first examine the extent to which the absence of p75 improves behavioural function following spinal cord injury. We will then use neurotrophin blockers to determine whether these molecules are indeed responsible for improved regeneration. We will also determine to what extent p75 is involved in transducing the effects of myelin. These studies will shed light on the function of a poorly-understood receptor with diverse effects. In the long term, this project may identify therapeutic targets for clinical intervention following spinal cord injury.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
250355-2007
Name nom
Ramer, Matt
Department département
Zoology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2007
Award amount
37210
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5108
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell movement
Research subject fr
Mouvements cellulaires
Partie
1
Nb partie
5
Application title
Axonal plasticity and the p75 neurotrophin receptor
Keyword
NA
Application summary
A balance between positive and negative influences govern the ability of nerve fibres (axons) to grow in the adult nervous system. Positive factors include a class of proteins known as neurotrophins, which if artificially provided in large amounts, are known to enhance axonal regeneration in the injured central nervous system CNS. Negative factors include proteins found in myelin, the insulation surrounding CNS axons. Blocking myelin's effects also improves axonal growth in the CNS. Both neurotrophins and myelin exert their effects on axons through complexes of receptors. Intriguingly, both complexes involve a receptor called p75, and genetically deleting p75 results in improved growth of axons in the CNS. Importantly, p75 deletion results in growth that is superior to that when all of the myelin-derived inhibitory proteins are blocked, and even when myelin is absent altogether. This suggests that p75 may also interfere with the growth-promoting ability of endogenously-expressed neurotrophins (those upregulated in response to injury). This proposal seeks to understand the mechanisms behind p75's role in preventing axon growth. It will use a combination of whole-animal (rats and mice) and tissue culture experiments to test the hypothesis that in the absence of p75 function, axon growth is enhanced due to increased efficacy of neurotrophins upregulated following CNS damage. We will first examine the extent to which the absence of p75 improves behavioural function following spinal cord injury. We will then use neurotrophin blockers to determine whether these molecules are indeed responsible for improved regeneration. We will also determine to what extent p75 is involved in transducing the effects of myelin. These studies will shed light on the function of a poorly-understood receptor with diverse effects. In the long term, this project may identify therapeutic targets for clinical intervention following spinal cord injury.